Companies / Newleos Therapeutics
Newleos Therapeutics
Boston, United States
Newleos Therapeutics is a clinical-stage biotechnology company that focuses on innovative neuropsychiatric mechanisms of action to treat mental health conditions.
Newleos Therapeutics, based in Boston, United States, has 1 investor on file, among them DCVC. Its site was last checked 14 Nov 2026: site answers.
SEC Form D filings
1 filingFiled by Newleos Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from DCVC
246 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (27%), AI & Machine Learning (22%), Developer Tools (15%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Newleos Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when DCVC adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/newleos.com/investors
# also
GET /v1/companies/newleos.com
GET /v1/companies/newleos.com/news